Parkinson's disease is the fastest growing neurological disorder, with more than 10 million cases worldwide. Up to 150,000 ...
Parkinson’s also presents and progresses differently in males and females. The study found women were younger than men at ...
One specialist in the condition explains why early diagnosis is critical and shares six lesser-known symptoms to be aware of ...
Post hoc analyses of two Phase 2 trials examine the potential benefits of solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, ...
A perspective in The Journal of Clinical Investigation argues that environmental exposures may interact with the gut ...
Speculation about Bill Clinton’s health has sparked renewed interest in Parkinson’s disease, a progressive neurological ...
Matricelf Ltd. (TASE: MTLF), a biotechnology company developing autologous engineered tissue therapies, today announced that it has signed a Memorandum of Understanding, subject to the execution of a ...
In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its ...
Medications like levodopa and carbidopa may help you manage Parkinson's disease. You can try physical therapy to improve your balance, gait, and motor function. Deep brain stimulation is a surgical ...
Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results